Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 31

1.

Treatment outcomes and tolerability of the revised WHO anti-tuberculosis drug dosages for children.

Nansumba M, Kumbakumba E, Orikiriza P, Bastard M, Mwanga JA, Boum Y, de Beaudrap P, Bonnet M.

Int J Tuberc Lung Dis. 2018 Feb 1;22(2):151-157. doi: 10.5588/ijtld.17.0535. Epub 2017 Dec 20.

PMID:
29262982
2.

Long-term Mortality and Disability in Cryptococcal Meningitis: A Systematic Literature Review.

Pasquier E, Kunda J, De Beaudrap P, Loyse A, Temfack E, Molloy SF, Harrison TS, Lortholary O.

Clin Infect Dis. 2018 Mar 19;66(7):1122-1132. doi: 10.1093/cid/cix870.

PMID:
29028957
3.

Outcome of Children With Presumptive Tuberculosis in Mbarara, Rural Uganda.

Bonnet M, Nansumba M, Bastard M, Orikiriza P, Kyomugasho N, Nansera D, Boum Y, de Beaudrap P, Kiwanuka J, Kumbakumba E.

Pediatr Infect Dis J. 2018 Feb;37(2):147-152. doi: 10.1097/INF.0000000000001727.

PMID:
28787386
4.

Prevalence of HIV infection among people with disabilities: a population-based observational study in Yaoundé, Cameroon (HandiVIH).

De Beaudrap P, Beninguisse G, Pasquier E, Tchoumkeu A, Touko A, Essomba F, Brus A, Aderemi TJ, Hanass-Hancock J, Eide AH, Mac-Seing M, Mont D.

Lancet HIV. 2017 Apr;4(4):e161-e168. doi: 10.1016/S2352-3018(16)30209-0. Epub 2017 Jan 24.

PMID:
28126484
5.

Getting pregnant in HIV clinical trials: women's choice and safety needs. The experience from the ANRS12169-2LADY and ANRS12286-MOBIDIP trials.

Serris A, Zoungrana J, Diallo M, Toby R, Mpoudi Ngolle M, Le Gac S, Coutherut J, Cournil A, De Beaudrap P, Koulla-Shiro S, Delaporte E, Ciaffi L.

HIV Clin Trials. 2016 Nov;17(6):233-241. Epub 2016 Nov 1.

PMID:
27801628
6.

Timing of malaria in pregnancy and impact on infant growth and morbidity: a cohort study in Uganda.

De Beaudrap P, Turyakira E, Nabasumba C, Tumwebaze B, Piola P, Boum Ii Y, McGready R.

Malar J. 2016 Feb 16;15:92. doi: 10.1186/s12936-016-1135-7.

7.

HandiVIH--A population-based survey to understand the vulnerability of people with disabilities to HIV and other sexual and reproductive health problems in Cameroon: protocol and methodological considerations.

De Beaudrap P, Pasquier E, Tchoumkeu A, Touko A, Essomba F, Brus A, Desgrées du Loû A, Aderemi TJ, Hanass-Hancock J, Eide AH, Mont D, Mac-Seing M, Beninguisse G.

BMJ Open. 2016 Feb 4;6(2):e008934. doi: 10.1136/bmjopen-2015-008934.

8.

Inhaled Nitric Oxide as an Adjunctive Treatment for Cerebral Malaria in Children: A Phase II Randomized Open-Label Clinical Trial.

Mwanga-Amumpaire J, Carroll RW, Baudin E, Kemigisha E, Nampijja D, Mworozi K, Santorino D, Nyehangane D, Nathan DI, De Beaudrap P, Etard JF, Feelisch M, Fernandez BO, Berssenbrugge A, Bangsberg D, Bloch KD, Boum Y 2nd, Zapol WM.

Open Forum Infect Dis. 2015 Jul 24;2(3):ofv111. doi: 10.1093/ofid/ofv111. eCollection 2015 Sep. Erratum in: Open Forum Infect Dis. 2015 Sep;2(3):ofv132.

9.

Early biting and insecticide resistance in the malaria vector Anopheles might compromise the effectiveness of vector control intervention in Southwestern Uganda.

Ojuka P, Boum Y 2nd, Denoeud-Ndam L, Nabasumba C, Muller Y, Okia M, Mwanga-Amumpaire J, De Beaudrap P, Protopopoff N, Etard JF.

Malar J. 2015 Apr 9;14:148. doi: 10.1186/s12936-015-0653-z.

10.

Impact of variability in adherence to HIV antiretroviral therapy on the immunovirological response and mortality.

Boussari O, Subtil F, Genolini C, Bastard M, Iwaz J, Fonton N, Etard JF, Ecochard R; ANRS 1215 study group.

BMC Med Res Methodol. 2015 Feb 5;15:10. doi: 10.1186/1471-2288-15-10.

11.

Disability and HIV: a systematic review and a meta-analysis of the risk of HIV infection among adults with disabilities in Sub-Saharan Africa.

De Beaudrap P, Mac-Seing M, Pasquier E.

AIDS Care. 2014;26(12):1467-76. doi: 10.1080/09540121.2014.936820. Epub 2014 Jul 17. Review.

PMID:
25033274
12.

[Clinical and biological effectiveness of antiretroviral therapy in the ANRS 1215 cohort].

De Beaudrap P, Diouf A, Bousso Niang K; groupe d’étude de la Cohorte ANRS 1215.

Bull Soc Pathol Exot. 2014 Oct;107(4):230-3. doi: 10.1007/s13149-014-0352-y. Epub 2014 Mar 11. French.

PMID:
24619515
13.

Use of colorimetric culture methods for detection of Mycobacterium tuberculosis complex isolates from sputum samples in resource-limited settings.

Boum Y 2nd, Orikiriza P, Rojas-Ponce G, Riera-Montes M, Atwine D, Nansumba M, Bazira J, Tuyakira E, De Beaudrap P, Bonnet M, Page AL.

J Clin Microbiol. 2013 Jul;51(7):2273-9. doi: 10.1128/JCM.00749-13. Epub 2013 May 8.

14.

Impact of malaria during pregnancy on pregnancy outcomes in a Ugandan prospective cohort with intensive malaria screening and prompt treatment.

De Beaudrap P, Turyakira E, White LJ, Nabasumba C, Tumwebaze B, Muehlenbachs A, Guérin PJ, Boum Y, McGready R, Piola P.

Malar J. 2013 Apr 24;12:139. doi: 10.1186/1475-2875-12-139.

15.

Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaboration.

Gabillard D, Lewden C, Ndoye I, Moh R, Segeral O, Tonwe-Gold B, Etard JF, Pagnaroat M, Fournier-Nicolle I, Eholié S, Konate I, Minga A, Mpoudi-Ngole E, Koulla-Shiro S, Zannou DM, Anglaret X, Laurent C; ANRS 12222 Morbidity Mortality Study Group.

J Acquir Immune Defic Syndr. 2013 Apr 15;62(5):555-61. doi: 10.1097/QAI.0b013e3182821821.

16.

Risk of virological failure and drug resistance during first and second-line antiretroviral therapy in a 10-year cohort in Senegal: results from the ANRS 1215 cohort.

De Beaudrap P, Thiam M, Diouf A, Toure-Kane C, Ngom-Guèye NF, Vidal N, Mboup S, Ndoye I, Sow PS, Delaporte E; ANRS 1215 Study Group.

J Acquir Immune Defic Syndr. 2013 Apr 1;62(4):381-7. doi: 10.1097/QAI.0b013e31827a2a7a.

PMID:
23117504
17.

Morbidity after antiretroviral therapy initiation in HIV-1-infected children in West Africa: temporal trends and relation to CD4 count.

De Beaudrap P, Boullé C, Lewden C, Gabillard D, Nacro B, Diagbouga S, Fassinou P, Hien H, Laurent C, Msellati P; ANRS 12222 Morbidity/Mortality Study Group.

Pediatr Infect Dis J. 2013 Apr;32(4):354-60. doi: 10.1097/INF.0b013e318278b222.

PMID:
23099424
18.

Reduced quantitative ultrasound bone mineral density in HIV-infected patients on antiretroviral therapy in Senegal.

Cournil A, Eymard-Duvernay S, Diouf A, Moquet C, Coutherut J, Ngom Gueye NF, Cames C, Taverne B, Bork K, Sow PS, Delaporte E; ANRS 1215 Study Group.

PLoS One. 2012;7(2):e31726. doi: 10.1371/journal.pone.0031726. Epub 2012 Feb 16.

19.

AIDS and non-AIDS morbidity and mortality across the spectrum of CD4 cell counts in HIV-infected adults before starting antiretroviral therapy in Cote d'Ivoire.

Anglaret X, Minga A, Gabillard D, Ouassa T, Messou E, Morris B, Traore M, Coulibaly A, Freedberg KA, Lewden C, Ménan H, Abo Y, Dakoury-Dogbo N, Toure S, Seyler C; ANRS 12222 Morbidity/Mortality Study Group.

Clin Infect Dis. 2012 Mar 1;54(5):714-23. doi: 10.1093/cid/cir898. Epub 2012 Feb 4.

20.

CD4-specific mortality rates among HIV-infected adults with high CD4 counts and no antiretroviral treatment in West Africa.

Lewden C, Gabillard D, Minga A, Ekouévi DK, Avit D, Konate I, Amani-Bossé C, Messou E, Coffie P, Ouedraogo A, Laurent C, Anglaret X; ANRS 12222 MorbidityMortality Study Group.

J Acquir Immune Defic Syndr. 2012 Feb 1;59(2):213-9. doi: 10.1097/QAI.0b013e31823b837e.

Supplemental Content

Loading ...
Support Center